https://www.medscape.com/viewarticle/995036
0
0
8/1/23 at 3:46pm
Organization
Medscape
Author
Richard Mark Kirkner
34 words
0
Comments
An early gene therapy trial reported maintenance of vision, reduced retinal inflammation, and detectable therapeutic protein levels 9 months after treatment for age-related macular degeneration.
You are the first to view
Create an account
or login to join the discussion